Dll4-Notch signaling in regulation of tumor angiogenesis

By Liu Zhaoguo   Fan Fangtian   Wang Aiyun   Zheng Shizhong   Lu Yin  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 4, 2014-04 ,pp. : 525-536

Springer Publishing Company

Access to resources Recommend Favorite

Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors

By Yu Fengbin   Miao Jinhao  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3371-3375

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical Evaluations of Therapies Combining the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate and Conventional Anticancer Therapies in the Treatment of Kaposi's Sarcoma

By Li Lingyun   Rojiani Amyn M.   Siemann Dietmar W.  

Acta Oncologica, Vol. 41, Iss. 1, 2002-02 ,pp. : 91-97

Informa Healthcare

Access to resources Recommend Favorite

huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models

By Lo Kin-Ming   Lan Yan   Lauder Scott   Zhang Jinyang   Brunkhorst Beatrice   Qin Guozhong   Verma Rakesh   Courtenay-Luck Nigel   Gillies Stephen  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 4, 2007-04 ,pp. : 447-457

Springer Publishing Company

Access to resources Recommend Favorite

Targeting of histone deacetylases in brain tumors

By Ecker Jonas   Witt Olaf   Milde Till  

CNS Oncology, Vol. 2, Iss. 4, 2013-07 ,pp. : 359-376

Future Medicine

Access to resources Recommend Favorite